CIK 0001411685 · Non-accelerated filer<br>Smaller reporting company
Vistagen Therapeutics, Inc.
Sign in to watch- Ticker
- VTGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 205093315
- Phone
- 650-577-3600
- Business address
- 343 ALLERTON AVENUE, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Excaliber Enterprises, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Returned to the company · Stock Option (Right to Buy) | −6,249 | 0 | ||
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +6,249 | 6,249 | ||
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Returned to the company · Stock Option (Right to Buy) | −6,251 | 0 | ||
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +6,251 | 6,251 | ||
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Returned to the company · Stock Option (Right to Buy) | −1,000 | 0 | ||
| 2013-12-20 | DOTSON JERROLD DUANE CFO AND SECRETARY | Grant or award · Stock Option (Right to Buy) | +1,000 | 1,000 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award | +100,000 | 100,000 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −60,000 | 0 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −22,500 | 0 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +22,500 | 22,500 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −1,000,000 | 0 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +1,000,000 | 1,000,000 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −425,000 | 0 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +425,000 | 425,000 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Stock Option (Right to Buy) | −40,000 | 0 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Grant or award · Stock Option (Right to Buy) | +40,000 | 40,000 | ||
| 2013-12-20 | Singh Shawn CHIEF EXECUTIVE OFFICER | Returned to the company · Warrant | −35,714 | 0 |
Page 22 of 28 · 544 trades